According to Massachusetts Attorney General Maura Healey, Walmart ( NYSE:WMT ) will pay the Commonwealth $500k to settle claims that it didn’t follow rules about how to price prescription medicines in the workers’ compensation insurance system.
According to Massachusetts law, medicine prices must be compared to predetermined regulatory benchmarks. For injured workers, the workers’ compensation system sets prescription drug cost caps.
Healey also worked out similar deals with Walgreens, which is owned by UnitedHealth Group (UNH), and Express Scripts, which is owned by Cigna (CI) (WBA).
Walmart ( NYSE:WMT ) unexpectedly issued a mid-quarter caution four months ago. The management cut their guidance in part as a result of too many inventories. Although it is common for corporations to cut their guidance in the middle of a quarter, when a firm of Walmart’s magnitude does so, it is undoubtedly causing concern.
Since then, the company has reported two more quarters. When the news first came out, the stock price dropped, but now there is more hope than fear about Walmart. We examine Walmart’s possibilities going into 2023:
Key Measures
Even though Walmart doesn’t need much of an introduction, there are a few things to think about when judging the company’s future.
Sales and Revenue Mix
Walmart US accounts for the majority of Walmart’s overall revenue. Sam’s Club ranks third overall in terms of revenue, but the trend is positive moving into 2023 as long as inflation and higher rates continue.
When it comes to revenue, groceries make up a much bigger share of sales at Walmart US than they should. This has prepared the business to profit from the current macroeconomic environment.
During Q3, same-store sales (SSS) at Walmart US went up an...
Click here to read the full article on PressReach.com .Subscribe to the PressReach RSS feeds:
- Featured News RSS feed
- Investing News RSS feed
- Daily Press Releases RSS feed
- Trading Tips RSS feed
- Investing Videos RSS feed
Follow PressReach on Twitter
Follow PressReach on TikTok
Follow PressReach on Instagram
Subscribe to us on Youtube